The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Thursday, August 06, 2020
Beroni has provided an update on the development of a potential medical solution utilizing nanobody technology for both detection and treatment of ...
read more
Wednesday, August 05, 2020
Constant announced its peptide drug TXA127 will be tested in a Phase 2 clinical trial at Columbia University Irving Medical Center in New York, New ...
read more
Wednesday, August 05, 2020
AbbVie announced the Phase 3 trial evaluating atogepant met its primary endpoint of statistically significantly greater reduction in mean monthly ...
read more
GlaxoSmithKline Pharmaceuticals
GSK has started shipping its quadrivalent influenza vaccines to US healthcare providers and pharmacies for the 2020-21 flu season.
read more
Intravacc and Celonic have signed a research agreement to further design, develop and produce a Covid-19 vaccine.
read more
INOVIO announced the FDA granted orphan drug designation for INO-3107, its DNA medicine being evaluated for recurrent respiratory papillomatosis.
read more
AstraZeneca Pharmaceuticals
AstraZeneca has entered into a new global development and commercialization agreement with Daiichi Sankyo for Daiichi Sankyo’s proprietary TROP2-...
read more
The first U.S. patients are being dosed in a Phase 2/3 clinical trial testing whether a mRNA vaccine candidate can prevent infection with the virus ...
read more
KemPharm announced the USPTO has recently issued two new patents to KemPharm governing methods of use and composition of matter for methylphenidate-...
read more
ProMedica announced promising results of its new study that evaluated the use of stem cells in the treatment of adult COVID-19 patients.
read more
AstraZeneca Pharmaceuticals
Imfinzi has been recommended for marketing authorization in the EU for the 1st-line treatment of adults with ES-SCLC in combination with a choice of ...
read more
Celsion announced the randomization of the first two patients in the Phase II portion of the Phase I/II OVATION 2 Study with GEN-1 in advanced ovarian...
read more
Emerald Health has begun enrollment and has dosed its first patients with diffuse cutaneous systemic sclerosis in its study EHP-101, an oral ...
read more
Concarlo announced a US Patent was issued by the USPTO for metastatic breast cancer.
read more
Immunic announced enrollment of the first patients in a trial of the company's selective oral DHODH inhibitor, IMU-838, for COVID-19.
read more